FLOREANI, ANNAROSA
 Distribuzione geografica
Continente #
NA - Nord America 20.128
EU - Europa 2.023
AS - Asia 1.194
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 3
SA - Sud America 3
Totale 23.363
Nazione #
US - Stati Uniti d'America 20.118
CN - Cina 949
IT - Italia 458
FI - Finlandia 435
DE - Germania 333
SE - Svezia 278
UA - Ucraina 228
GB - Regno Unito 177
VN - Vietnam 161
IE - Irlanda 40
IN - India 27
FR - Francia 21
HK - Hong Kong 17
NL - Olanda 16
JP - Giappone 12
ES - Italia 10
PK - Pakistan 7
SG - Singapore 7
BG - Bulgaria 6
CA - Canada 6
EU - Europa 6
IQ - Iraq 6
PL - Polonia 6
AU - Australia 5
GR - Grecia 3
MX - Messico 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CH - Svizzera 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
RU - Federazione Russa 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
Totale 23.363
Città #
Fairfield 3.474
Woodbridge 2.251
Houston 1.801
Ann Arbor 1.590
Ashburn 1.465
Chandler 1.398
Wilmington 1.287
Seattle 1.260
Cambridge 1.204
Jacksonville 1.105
Princeton 500
San Diego 360
Beijing 292
Medford 241
Nanjing 202
Des Moines 183
Roxbury 177
Padova 169
Dong Ket 160
Helsinki 143
Boardman 130
Guangzhou 57
Hebei 54
Shenyang 53
London 51
Norwalk 50
Nanchang 49
New York 47
Jiaxing 44
Dublin 40
Falls Church 40
Redwood City 34
Changsha 32
Tianjin 31
Kharkiv 20
Jinan 19
Hong Kong 16
Ogden 16
Shanghai 15
Milan 14
Bergamo 13
Borås 13
Hounslow 11
Kilburn 11
Indiana 10
Nürnberg 10
Rockville 10
Rome 10
Salerno 10
Washington 10
Detroit 9
Chicago 8
Dearborn 8
Origgio 8
Taizhou 8
Kunming 7
Los Angeles 7
Ningbo 7
Taiyuan 7
Tappahannock 7
Haikou 6
Sofia 6
Zhengzhou 6
A Coruña 5
Chiswick 5
Hirakata 5
Marostica 5
Munich 5
Naples 5
Phoenix 5
Treviso 5
Acton 4
Amsterdam 4
Boston 4
Hefei 4
Montecorvino Rovella 4
New Bedfont 4
Prescot 4
Pune 4
Redmond 4
Sahiwal 4
Tokyo 4
Venice 4
Verona 4
Vicenza 4
Aix-en-Provence 3
Baghdad 3
Brendola 3
Dallas 3
Florence 3
Fuzhou 3
Hangzhou 3
Hyderabad 3
Lappeenranta 3
Mestre 3
Mosul 3
Nole 3
Paluello 3
Paris 3
Rovigo 3
Totale 20.417
Nome #
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 159
Extrahepatic autoimmunity in autoimmune liver disease 139
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 136
Heparanase and macrophage interplay in the onset of liver fibrosis 136
The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report 134
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 133
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 132
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 129
Coronary flow reserve in patients with primary biliary cholangitis 129
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 126
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis 124
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 121
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 119
Ursodeoxycholic Acid Therapy and Liver Transplant-free Survival in Patients with Primary Biliary Cholangitis 119
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 119
Is osteopenia a peculiar association with primary biliary cirrhosis (PBC)? 116
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 114
Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis 113
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy. 112
Functional differentiation of human pluripotent stem cells on a chip 111
Preventative therapy in primary biliary cirrhosis 110
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 109
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 108
Viral load in HCV RNA-positive pregnant women. 108
Hepatitis C virus infection in pregnancy. 107
BRIC AUTOSOMAL DOMINANT BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC) UNLINKED TO 18Q 21 LOCUS: IS IT A NEW ENTITY? 107
Acute hepatitis in elderly patients. 107
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 107
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)? 106
Functional differentiation of human pluripotent stem cells on a chip. 106
Primary biliary cirrhosis: overlaps with other autoimmune disorders 106
Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis. 105
Colchicine in chronic hepatitis B: a pilot study 104
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications 104
A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. 103
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 103
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 103
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 103
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload 103
Primary biliary cirrhosis: report of a focus study group. 102
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 102
Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis 102
Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. 101
Familial primary biliary cirrhosis and autoimmune cholangitis 100
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 100
Hepatitis C and pregnancy 100
Gender medicine: a task for the third millennium. 99
Primary biliary cholangitis: Old and novel therapy 98
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 98
In vitro metabolic zonation through oxygen gradient on a chip 98
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 97
Liver transplantation and pregnancy. 97
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a Southern European population 96
Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C 96
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 96
AISF position paper on liver disease and pregnancy 96
Y chromosome loss in male patients with primary biliary cirrhosis 94
A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. 94
null 93
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. 93
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. 93
Bone metabolism in orthotopic liver transplantation: a prospective study. 93
Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. 93
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 93
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 93
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 93
Primary biliary cirrhosis and hepatitis C virus infection 92
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis 92
Prevalence of familial disease in primary biliary cirrhosis in Italy 92
New Insights on Intrahepatic Cholestasis of Pregnancy 92
An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy 91
Lack of increased frequency of the CC chemokine receptor 5-DELTA32/DELTA32 genotype in Hepatitis C 91
Type 1 autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study 91
Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). 91
Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C 90
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 90
Are homes for the elderly still a risk area for HBV infection? 90
Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle 90
TTV infection in patients with acute hepatitis of defined aetiology and in acute non-A-E hepatitis 90
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival 90
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 90
Intrafamilial transmission of hepatitis C virus infection 88
Response to influenza vaccine in people with non-protective HI antibody titers. 88
Activation of the IGF1 system characterizes cholangiocyte survival duringprogression of primary biliary cirrhosis. 88
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 88
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 88
Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents. 88
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 87
Etiopathogenesis of autoimmune hepatitis 87
Type-1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. 87
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 87
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 87
HEPATOCELLULAR PROLIFERATION, TNF-ALPHA AND INFLAMMATION IN PRIMARY BILIARY-CIRRHOSIS (PBC) 86
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 86
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation 86
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. 85
THE EARLY DIAGNOSIS IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS: A 35-YEAR FOLLOW-UP IN A SINGLE CENTRE 85
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis 85
THE ENDOCANNABINOID SYSTEM IS UP-REGULATED IN PRIMARY BILIARY CIRRHOSIS 84
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. 84
Totale 10.146
Categoria #
all - tutte 81.341
article - articoli 74.999
book - libri 243
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.963
Totale 158.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.657 0 0 0 0 0 0 0 0 0 0 892 765
2019/20205.456 784 208 97 554 602 439 482 612 588 544 291 255
2020/20213.449 152 261 236 360 121 220 85 361 501 368 478 306
2021/20224.500 129 525 668 280 225 264 250 481 187 90 476 925
2022/20233.083 681 273 53 328 504 437 47 228 327 16 154 35
2023/20241.004 66 188 158 116 72 127 81 104 53 37 2 0
Totale 23.614